Cardiology

Olmesartan products

The AT1-antagonist olmesartan is a highly potent antihypertensive agent1 that offers additional protective properties for the vasculature2: Therapy with olmesartan further leads to a significant volume reduction of atherosclerotic plaques3, independent of blood pressure reduction.

References: 1 Fabia M.J. et al.; Journal of Hypertension( 2007), 25: 1327 - 1336, 2 Fliser D. et al.; Circulation Vol. 110 No 9 (2004): 1103-1107, 3 Stumpe K. et al.; Ther Adv in Cardiovasc Disease (2007): 97-106
 

Mencord®/Mencord® Plus

Mencord® (olmesartan) is a drug for the treatment of essential hypertension. The AT1-receptor antagonist olmesartan is offered by A. Menarini Pharma GmbH as Mencord® film-coated tablets in the strengths 10, 20 and 40 mg olmesartan medoxomil for the treatment of essential hypertension in adults and for the treatment of hypertension in children and adolescents aged 6 to 18 years.

In addition to the monopreparation Mencord® (olmesartan), the combination preparation Mencord® Plus (olmesartan + hydrochlorothiazide) is also available and leads to an additive increase in efficacy.

AT-WEB-12-10-2021

 

image-menarini-product-mencord-q637948582775632995

image-menarini-product-mencord-plus


Mencord® (olmesartan) is available in the following package sizes and dosages:
28 film-coated tablets - 10 mg
28 film-coated tablets - 20 mg
28 film-coated tablets - 40 mg

Mencord® Plus (olmesartan + hydrochlorothiazide) is available in the following package sizes and dosages:
28 film-coated tablets - 20 mg/12.5 mg (1)
28 film-coated tablets - 20 mg/25 mg (1)
28 Film-Coated Tablets - 40 mg/12.5 mg (2)
28 Film-Coated Tablets - 40 mg/25 mg (2)




Dear visitor, the gender form selected on our homepage always refers to female, male and various people at the same time. We have refrained from using a gender-specific spelling or multiple designations solely for the purpose of better readability. All personal designations are to be understood as gender-neutral.

Liebe Besucherin, lieber Besucher, die auf unserer Homepage gewählte Geschlechtsform bezieht sich immer zugleich auf weibliche, männliche und diverse Personen. Wir haben ausschließlich zum Zweck der besseren Lesbarkeit auf eine geschlechtsspezifische Schreibweise bzw. auf eine Mehrfachbezeichnung verzichtet. Alle personenbezogenen Bezeichnungen sind geschlechtsneutral zu verstehen.

A. Menarini Pharma Gesellschaft mit beschränkter Haftung
Firmenbuchnummer: FN 177062k
Firmenbuchgericht: Handelsgericht Wien
UID-Nummer: ATU 46203601

A. Menarini Pharma limited liability company
Commercial register number: FN 177062k
Commercial register court: Commercial Court Vienna
VAT-Number: ATU 46203601

© 2024 Menarini Austria - All rights reserved